| Phenotype details |
see paper; focal segmental glomerulosclerosis, podocyte hypertrophy, no end-stage kidney disease; head circumference (5m -2 SD, 10y -3 SDs), hypertonia, ID, spasticity, cerebellar atrophy, thin corpus callosum, subtentorial atrophy, ventricular dilation, facial dysmorphy, abnormal visual evoked potentials, optic atrophy, ... |